全文获取类型
收费全文 | 71962篇 |
免费 | 6989篇 |
国内免费 | 54篇 |
出版年
2022年 | 540篇 |
2021年 | 1151篇 |
2020年 | 583篇 |
2019年 | 788篇 |
2018年 | 976篇 |
2017年 | 893篇 |
2016年 | 1608篇 |
2015年 | 2750篇 |
2014年 | 3005篇 |
2013年 | 3729篇 |
2012年 | 4728篇 |
2011年 | 4783篇 |
2010年 | 3150篇 |
2009年 | 2831篇 |
2008年 | 4181篇 |
2007年 | 4239篇 |
2006年 | 3987篇 |
2005年 | 3913篇 |
2004年 | 3815篇 |
2003年 | 3674篇 |
2002年 | 3583篇 |
2001年 | 958篇 |
2000年 | 763篇 |
1999年 | 983篇 |
1998年 | 1025篇 |
1997年 | 734篇 |
1996年 | 658篇 |
1995年 | 631篇 |
1994年 | 602篇 |
1993年 | 598篇 |
1992年 | 611篇 |
1991年 | 562篇 |
1990年 | 566篇 |
1989年 | 484篇 |
1988年 | 490篇 |
1987年 | 496篇 |
1986年 | 471篇 |
1985年 | 556篇 |
1984年 | 569篇 |
1983年 | 520篇 |
1982年 | 602篇 |
1981年 | 596篇 |
1980年 | 562篇 |
1979年 | 412篇 |
1978年 | 446篇 |
1977年 | 422篇 |
1976年 | 400篇 |
1975年 | 317篇 |
1974年 | 424篇 |
1973年 | 359篇 |
排序方式: 共有10000条查询结果,搜索用时 25 毫秒
41.
42.
Following arteriolar occlusion, tissue oxygen concentration decreases and anoxic tissue eventually develops. Although anoxia
first appears in the region most distal to the capillary at the venous end, it eventually spreads throughout the entire region
of supply. In this paper the changing oxygen concentration, from the time of occlusion until the tissue is entirely anoxic,
is examined mathematically. The equations governing oxygen transport to tissue are solved by iterating a nonlinear integral
equation. This solution is valid until anoxia first appears. After anoxia develops it is necessary to solve a moving boundary
problem. This is done using the method of matched asymptotic expansions, and accurate solutions are obtained for a wide range
of physiological conditions. 相似文献
43.
Sharat J. Vayttaden Jacqueline Friedman Tuan M. Tran Thomas C. Rich Carmen W. Dessauer Richard B. Clark 《PLoS computational biology》2010,6(1)
We developed a unified model of the GRK-mediated β2 adrenergic receptor (β2AR) regulation that simultaneously accounts for six different biochemical measurements of the system obtained over a wide range of agonist concentrations. Using a single deterministic model we accounted for (1) GRK phosphorylation in response to various full and partial agonists; (2) dephosphorylation of the GRK site on the β2AR; (3) β2AR internalization; (4) recycling of the β2AR post isoproterenol treatment; (5) β2AR desensitization; and (6) β2AR resensitization. Simulations of our model show that plasma membrane dephosphorylation and recycling of the phosphorylated receptor are necessary to adequately account for the measured dephosphorylation kinetics. We further used the model to predict the consequences of (1) modifying rates such as GRK phosphorylation of the receptor, arrestin binding and dissociation from the receptor, and receptor dephosphorylation that should reflect effects of knockdowns and overexpressions of these components; and (2) varying concentration and frequency of agonist stimulation “seen” by the β2AR to better mimic hormonal, neurophysiological and pharmacological stimulations of the β2AR. Exploring the consequences of rapid pulsatile agonist stimulation, we found that although resensitization was rapid, the β2AR system retained the memory of the previous stimuli and desensitized faster and much more strongly in response to subsequent stimuli. The latent memory that we predict is due to slower membrane dephosphorylation, which allows for progressive accumulation of phosphorylated receptor on the surface. This primes the receptor for faster arrestin binding on subsequent agonist activation leading to a greater extent of desensitization. In summary, the model is unique in accounting for the behavior of the β2AR system across multiple types of biochemical measurements using a single set of experimentally constrained parameters. It also provides insight into how the signaling machinery can retain memory of prior stimulation long after near complete resensitization has been achieved. 相似文献
44.
45.
46.
47.
48.
During the progression of malignant peritoneal mesothelioma (MPeM), tumor nodules propagate diffusely within the abdomen and tumors are characterized by distinct phenotypic sub-types. Recent studies in solid organ cancers have shown that cancer stem cells (CSCs) play a pivotal role in the initiation and progression of tumors. However, it is not known whether tumorigenic stem cells exist and whether they promote tumor growth in MPeM. In this study, we developed and characterized a CSC model for MPeM using stably expandable tumorigenic stem cells derived from patient tumors. We found morphologically distinct populations of CSCs that divide asymmetrically or symmetrically in MPeM in vitro cell culture. The MPeM stem cells (MPeMSCs) express stem cell markers c-MYC, NES and VEGFR2 and in the presence of matrix components cells form colony spheres. MPeMSCs are multipotent, differentiate into neuronal, vascular and adipose progeny upon defined induction and the differentiating cells express lineage-specific markers such as TUBB3, an early neuronal marker; vWF, VEGFA, VEGFC and IL-8, endothelial markers; and PPARγ and FABP4, adipose markers. Xenotransplantation experiments using MPeMSCs demonstrated early tumor growth compared with parental cells. Limiting dilution experiments using MPeMSCs and endothelial lineage-induced cells derived from a single MPeMSC resulted in early tumor growth in the latter group indicating that endothelial differentiation of MPeMSCs is important for MPeM tumor initiation. Our observation that the MPeM tumors contain stem cells with tumorigenic potential has important implications for understanding the cells of origin and tumor progression in MPeM and hence targeting CSCs may be a useful strategy to inhibit malignant progression. 相似文献
49.
50.
Anthony J. Hesketh Caroline Maloney Christopher A. Behr Morris C. Edelman Richard D. Glick Yousef Al-Abed Marc Symons Samuel Z. Soffer Bettie M. Steinberg 《PloS one》2015,10(12)
Metastatic Ewing Sarcoma carries a poor prognosis, and novel therapeutics to prevent and treat metastatic disease are greatly needed. Recent evidence demonstrates that tumor-associated macrophages in Ewing Sarcoma are associated with more advanced disease. While some macrophage phenotypes (M1) exhibit anti-tumor activity, distinct phenotypes (M2) may contribute to malignant progression and metastasis. In this study, we show that M2 macrophages promote Ewing Sarcoma invasion and extravasation, pointing to a potential target of anti-metastatic therapy. CNI-1493 is a selective inhibitor of macrophage function and has shown to be safe in clinical trials as an anti-inflammatory agent. In a xenograft mouse model of metastatic Ewing Sarcoma, CNI-1493 treatment dramatically reduces metastatic tumor burden. Furthermore, metastases in treated animals have a less invasive morphology. We show in vitro that CNI-1493 decreases M2-stimulated Ewing Sarcoma tumor cell invasion and extravasation, offering a functional mechanism through which CNI-1493 attenuates metastasis. These data indicate that CNI-1493 may be a safe and effective adjuvant agent for the prevention and treatment of metastatic Ewing Sarcoma. 相似文献